UBS Group’s Acer Therapeutics Inc Warrant ACERW Stock Holding History

UBS Group’s Portfolio ACERW Stock Details ACERW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-38,651	Closed	–	–	8612
2018 Q1	$0	Buy	38,651 +31,793	+464%	+$251	﹤0.01%	8473
2017 Q4	$0	Sell	6,858 -48,120	-88%	-$1.6K	﹤0.01%	8351
2017 Q3	$4K	Buy	+54,978	New	+$4.52K	﹤0.01%	7361

UBS Group's ACERW Position: Q2 2018 in Review

UBS Group sold out of Acer Therapeutics Inc Warrant (ACERW) in Q2 2018, closing a stake of 38,651 shares.

UBS Group first reported a position in ACERW in Q3 2017 and held it in 3 quarters. The position peaked at $4K in Q3 2017. 0 funds tracked by Wall St. Rank hold ACERW as of Q2 2018.

UBS Group reported no remaining Acer Therapeutics Inc Warrant position as of Q2 2018 after selling out during the quarter.
UBS Group sold 38,651 Acer Therapeutics Inc Warrant shares in Q2 2018.
UBS Group first reported a position in Acer Therapeutics Inc Warrant in Q3 2017 and held it in 3 quarters.
UBS Group's Acer Therapeutics Inc Warrant position peaked at $4K in Q3 2017.
0 funds tracked by Wall St. Rank held Acer Therapeutics Inc Warrant as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.